Stocks
Aditxt, Inc.ADTX
PNKHealthcareBiotechnology$0.00
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing immunotherapies for autoimmune diseases and viral infections, with a focus on antigen-specific tolerance. Its lead programs target conditions like multiple sclerosis and type 1 diabetes, and investors track it for its pipeline progress and regulatory milestones.
52W Range: $0.00-$8127.86
Congressional Interest in Aditxt, Inc. (ADTX)
No congressional trades have been disclosed for Aditxt, Inc. (ADTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ADTX?
No congressional trades found for this stock.